Mutations in BRAF, a regulator of the mitogen-activated protein-kinase kinase (MAPKK)-ERK1/2 pathway, are associated with approximately 70% of melanomas; the most common mutants are BRAFV599E and BRAFV600E[26], [27]. This evidence concerns the gene WNK2 and melanoma.